Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) Shares Outstanding (Weighted Average) (2016 - 2025)

Ocugen's Shares Outstanding (Weighted Average) history spans 12 years, with the latest figure at $300.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 548202.11% year-over-year to $300.2 million; the TTM value through Dec 2025 reached $300.2 million, up 548202.11%, while the annual FY2025 figure was $300.2 million, 548202.11% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $300.2 million in Q4 2025 per OCGN's latest filing, up from $20.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $300.2 million in Q4 2025 to a low of $54745.0 in Q2 2024.
  • Average Shares Outstanding (Weighted Average) over 5 years is $194.2 million, with a median of $215.2 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding (Weighted Average): surged 18629712.2% in 2021, then crashed 99.98% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $195.0 million in 2021, then increased by 10.04% to $214.6 million in 2022, then increased by 13.85% to $244.3 million in 2023, then plummeted by 99.98% to $54745.0 in 2024, then soared by 548202.11% to $300.2 million in 2025.
  • Per Business Quant, the three most recent readings for OCGN's Shares Outstanding (Weighted Average) are $300.2 million (Q4 2025), $20.6 million (Q3 2025), and $292.1 million (Q2 2025).